PL363965A1 - Przeciwgrzybicza kompozycja o zwiększonej dostępności biologicznej - Google Patents

Przeciwgrzybicza kompozycja o zwiększonej dostępności biologicznej

Info

Publication number
PL363965A1
PL363965A1 PL02363965A PL36396502A PL363965A1 PL 363965 A1 PL363965 A1 PL 363965A1 PL 02363965 A PL02363965 A PL 02363965A PL 36396502 A PL36396502 A PL 36396502A PL 363965 A1 PL363965 A1 PL 363965A1
Authority
PL
Poland
Prior art keywords
antifungal composition
enhanced bioavailability
bioavailability
enhanced
antifungal
Prior art date
Application number
PL02363965A
Other languages
English (en)
Other versions
PL212985B1 (pl
Inventor
Stefan Sharpe
Joel Sequeira
David Harris
Shashank Mahashabde
Original Assignee
Schering Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23076102&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL363965(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corporation filed Critical Schering Corporation
Publication of PL363965A1 publication Critical patent/PL363965A1/pl
Publication of PL212985B1 publication Critical patent/PL212985B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/64—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
    • A01N43/647—Triazoles; Hydrogenated triazoles
    • A01N43/653—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dentistry (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Dispersion Chemistry (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL363965A 2001-04-03 2002-04-01 Ciekla zawiesina zawierajaca przeciwgrzybiczo skuteczna ilosc posakonazolu oraz zastosowanie zmikronizowanych czastek posakonazolu PL212985B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28113901P 2001-04-03 2001-04-03
PCT/US2002/010093 WO2002080678A1 (en) 2001-04-03 2002-04-01 Antifungal composition with enhanced bioavailability

Publications (2)

Publication Number Publication Date
PL363965A1 true PL363965A1 (pl) 2004-11-29
PL212985B1 PL212985B1 (pl) 2012-12-31

Family

ID=23076102

Family Applications (1)

Application Number Title Priority Date Filing Date
PL363965A PL212985B1 (pl) 2001-04-03 2002-04-01 Ciekla zawiesina zawierajaca przeciwgrzybiczo skuteczna ilosc posakonazolu oraz zastosowanie zmikronizowanych czastek posakonazolu

Country Status (18)

Country Link
US (2) US20030055067A1 (pl)
EP (2) EP2090165A3 (pl)
JP (2) JP4308902B2 (pl)
KR (1) KR100607742B1 (pl)
CN (1) CN100415234C (pl)
AR (1) AR033096A1 (pl)
AU (1) AU2002257104B2 (pl)
BR (1) BR0208626A (pl)
CA (1) CA2443089C (pl)
HU (1) HUP0400856A3 (pl)
MX (1) MXPA03009021A (pl)
NO (1) NO20034419L (pl)
NZ (1) NZ528363A (pl)
PE (1) PE20020994A1 (pl)
PL (1) PL212985B1 (pl)
TW (1) TWI311464B (pl)
WO (1) WO2002080678A1 (pl)
ZA (1) ZA200307684B (pl)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7193084B2 (en) 2000-12-22 2007-03-20 Baxter International Inc. Polymorphic form of itraconazole
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US8067032B2 (en) 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US20030072807A1 (en) * 2000-12-22 2003-04-17 Wong Joseph Chung-Tak Solid particulate antifungal compositions for pharmaceutical use
MXPA04002446A (es) 2001-09-26 2004-07-23 Baxter Int Preparacion de nanoparticulas de tamano de submicras mediante dispersion y remocion de la fase liquida o solvente.
US20060009469A1 (en) * 2004-05-28 2006-01-12 Leonore Witchey-Lakshmanan Particulate-stabilized injectable pharmacutical compositions of posaconazole
CN1988887A (zh) * 2004-05-28 2007-06-27 先灵公司 包含泊沙康唑的注射用药物混悬剂
US20060160823A1 (en) * 2004-05-28 2006-07-20 Leonore Witchey-Lakshmanan Particulate-stabilized injectable pharmaceutical compositions of Posaconazole
US7473684B2 (en) * 2005-09-16 2009-01-06 Selamine Limited Bisphosphonate formulation
CN101495096A (zh) 2006-05-30 2009-07-29 伊兰制药国际有限公司 纳米微粒泊沙康唑制剂
KR101403135B1 (ko) 2006-06-14 2014-06-19 인터벳 인터내셔널 비.브이. 벤지미다졸 카르바메이트 및 폴리솔베이트를 포함하는 현탁물
GB0624087D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril combination salt
GB0624090D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amine salts
GB0624084D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amino acid salts
FR2910323A1 (fr) * 2006-12-26 2008-06-27 Virbac Sa Sa Composition liquide anhydre destinee a etre incorporee a l'eau de boisson des animaux d'elevage.
DE102008004893A1 (de) 2008-01-17 2009-07-23 Add Technologies Ltd. Trägerpellets, Verfahren zu deren Herstellung und deren Verwendung
EP2278957A2 (en) * 2008-04-15 2011-02-02 Schering Corporation Oral pharmaceutical compositions in a solid dispersion comprising preferably posaconazole and hpmcas
WO2009129300A2 (en) * 2008-04-15 2009-10-22 Schering Corporation High density compositions containing posaconazole and formulations comprising the same
EP2130540A1 (en) * 2008-06-02 2009-12-09 Sandoz AG Pharmaceutical compositions containing a crystalline form of posaconazole
EP2141159A1 (en) 2008-07-03 2010-01-06 Sandoz AG A Crystalline form of posaconazole
CA2767489A1 (en) 2009-07-09 2011-01-13 Sandoz Ag A crystalline form of posaconazole
EP2571847B1 (en) 2010-05-19 2016-09-21 Sandoz AG Process for the preparation of chiral hydrazides
CN102892763B (zh) 2010-05-19 2016-03-09 桑多斯股份公司 泊沙康唑及泊沙康唑中间体的纯化
US9073904B2 (en) 2010-05-19 2015-07-07 Sandoz Ag Preparation of posaconazole intermediates
AU2011254654B2 (en) 2010-05-19 2016-01-07 Sandoz Ag Process for the preparation of chiral triazolones
CN103635465A (zh) 2011-06-16 2014-03-12 桑多斯股份公司 制备手性化合物的方法
US20150164890A1 (en) 2012-06-14 2015-06-18 Sandoz Ag Pharmaceutical compositions comprising crystalline posaconazole
WO2016087880A1 (en) 2014-12-05 2016-06-09 Pulmocide Limited Antimycotic compound
ES2790723T3 (es) 2015-05-21 2020-10-29 Pulmocide Ltd Antifúngico 4-(4-(4-(((3R,5R)-5-((1H-1,2,4-triazol-1-il)metil)-5-(2,4-difluorofenil)tetrahidrofurano-3-il)metoxi)-3-metilfenil)piperazina-1-il)-N -(2-hidroxiciclohexil)benzamida, o una sal farmacéuticamente aceptable del mismo
CN105030668B (zh) * 2015-06-26 2018-03-27 济川药业集团有限公司 泊沙康唑口服混悬剂及其制备方法
CN106333925B (zh) * 2015-07-10 2019-06-18 上海美悦生物科技发展有限公司 一种泊沙康唑液体混悬剂及其制备方法
MX376201B (es) * 2015-12-30 2025-03-07 Nqp 1598 Ltd Compuestos inhibidores de metaloenzima.
CN106389390A (zh) * 2016-06-30 2017-02-15 重庆华邦制药有限公司 泊沙康唑涂膜剂及其制备方法
CN107625729A (zh) * 2017-09-29 2018-01-26 重庆华邦制药有限公司 泊沙康唑口服混悬液及其制备方法
CN110507609B (zh) * 2018-05-21 2021-09-17 上海医药工业研究院 泊沙康唑口服混悬剂的制备方法
GB201917867D0 (en) 2019-12-06 2020-01-22 Pulmocide Ltd Polymorphs
IL298010A (en) * 2020-05-12 2023-01-01 Cellix Bio Private Ltd A process for preparing salts of triazole compounds

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4533254A (en) 1981-04-17 1985-08-06 Biotechnology Development Corporation Apparatus for forming emulsions
US4788220A (en) * 1987-07-08 1988-11-29 American Home Products Corporation (Del.) Pediatric ibuprofen compositions
NZ234143A (en) * 1989-06-28 1991-10-25 Mcneil Ppc Inc Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
US5399363A (en) 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
US5552160A (en) 1991-01-25 1996-09-03 Nanosystems L.L.C. Surface modified NSAID nanoparticles
AU642066B2 (en) 1991-01-25 1993-10-07 Nanosystems L.L.C. X-ray contrast compositions useful in medical imaging
US5661151A (en) * 1993-12-21 1997-08-26 Schering Corporation Tetrahydrofuran antifungals
DK0736030T3 (da) * 1993-12-21 2001-10-29 Schering Corp Fungicide tetrahydrofuraner
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
US5580579A (en) * 1995-02-15 1996-12-03 Nano Systems L.L.C. Site-specific adhesion within the GI tract using nanoparticles stabilized by high molecular weight, linear poly (ethylene oxide) polymers
CA2238048A1 (en) * 1995-11-20 1997-05-29 Hiromasa Okada Antifungal composition
US5834472A (en) * 1996-05-24 1998-11-10 Schering Corporation Antifungal composition with enhanced bioavailability
US5846971A (en) 1996-06-28 1998-12-08 Schering Corporation Oral antifungal composition
EP0995435B1 (en) * 1997-05-14 2007-04-25 Senju Pharmaceutical Co., Ltd. Aqueous suspension preparations with excellent redispersibility
AU764001B2 (en) 1998-05-29 2003-08-07 Skyepharma Canada Inc. Thermoprotected microparticle compositions and process for terminal steam sterilization thereof
US20050048126A1 (en) * 2000-12-22 2005-03-03 Barrett Rabinow Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug

Also Published As

Publication number Publication date
HUP0400856A3 (en) 2012-09-28
WO2002080678A1 (en) 2002-10-17
KR20030087052A (ko) 2003-11-12
HUP0400856A2 (hu) 2004-08-30
TWI311464B (en) 2009-07-01
JP4308902B2 (ja) 2009-08-05
NZ528363A (en) 2005-04-29
CA2443089C (en) 2011-11-01
US20030055067A1 (en) 2003-03-20
EP1372394A1 (en) 2004-01-02
JP2008120836A (ja) 2008-05-29
AU2002257104B2 (en) 2006-02-09
AR033096A1 (es) 2003-12-03
KR100607742B1 (ko) 2006-08-01
US20110244004A1 (en) 2011-10-06
PE20020994A1 (es) 2002-11-01
JP2004527525A (ja) 2004-09-09
PL212985B1 (pl) 2012-12-31
CA2443089A1 (en) 2002-10-17
EP2090165A3 (en) 2012-03-28
US8263600B2 (en) 2012-09-11
EP2090165A2 (en) 2009-08-19
NO20034419L (no) 2003-12-02
MXPA03009021A (es) 2004-02-12
NO20034419D0 (no) 2003-10-02
ZA200307684B (en) 2005-03-30
BR0208626A (pt) 2004-03-09
CN1499930A (zh) 2004-05-26
CN100415234C (zh) 2008-09-03

Similar Documents

Publication Publication Date Title
MXPA03009021A (es) Composicion antifungal con biodisponibilidad aumentada.
IL157334A0 (en) Topical composition comprising an antifungal
GB0114069D0 (en) Composition
GB0107651D0 (en) Composition
GB0122113D0 (en) Composition
GB0130110D0 (en) Composition
GB0115679D0 (en) Composition
GB0219752D0 (en) Composition
GB0219751D0 (en) Composition
AU2002367173A8 (en) Antifungal compositions
GB0117305D0 (en) Composition
GB0126081D0 (en) Composition
GB2374899B (en) Stays
GB2377213B (en) Forklift
GB0219747D0 (en) Composition
GB0121454D0 (en) Composition
HK1057148A (en) Antifungal composition with enhanced bioavailability
AU2002368223A8 (en) Antifungal compositions
GB0122698D0 (en) Antifungal drugs
GB0327934D0 (en) Composition
GB0126085D0 (en) Composition
GB0113366D0 (en) Composition
GB0124271D0 (en) Composition
GB0126362D0 (en) Composition
GB0114067D0 (en) Composition